WO2014151431A2 - Method and apparatus for transdermal stimulation over the palmar and plantar surfaces - Google Patents
Method and apparatus for transdermal stimulation over the palmar and plantar surfaces Download PDFInfo
- Publication number
- WO2014151431A2 WO2014151431A2 PCT/US2014/025718 US2014025718W WO2014151431A2 WO 2014151431 A2 WO2014151431 A2 WO 2014151431A2 US 2014025718 W US2014025718 W US 2014025718W WO 2014151431 A2 WO2014151431 A2 WO 2014151431A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stimulation
- nerve
- applicator
- sensor
- electrode
- Prior art date
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 376
- 238000000034 method Methods 0.000 title claims abstract description 126
- 210000005036 nerve Anatomy 0.000 claims abstract description 332
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 143
- 210000002972 tibial nerve Anatomy 0.000 claims description 112
- 210000001519 tissue Anatomy 0.000 claims description 92
- 210000003205 muscle Anatomy 0.000 claims description 90
- 210000003491 skin Anatomy 0.000 claims description 89
- 208000002193 Pain Diseases 0.000 claims description 51
- 206010046543 Urinary incontinence Diseases 0.000 claims description 41
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 39
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 38
- 208000020629 overactive bladder Diseases 0.000 claims description 38
- 230000036407 pain Effects 0.000 claims description 38
- 230000007830 nerve conduction Effects 0.000 claims description 35
- 230000007383 nerve stimulation Effects 0.000 claims description 30
- 238000001514 detection method Methods 0.000 claims description 26
- 230000004936 stimulating effect Effects 0.000 claims description 26
- 208000005793 Restless legs syndrome Diseases 0.000 claims description 23
- 208000034347 Faecal incontinence Diseases 0.000 claims description 17
- 230000001953 sensory effect Effects 0.000 claims description 17
- 206010052804 Drug tolerance Diseases 0.000 claims description 15
- 230000005672 electromagnetic field Effects 0.000 claims description 15
- 230000026781 habituation Effects 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 14
- 208000000094 Chronic Pain Diseases 0.000 claims description 13
- 230000004007 neuromodulation Effects 0.000 claims description 13
- 210000000578 peripheral nerve Anatomy 0.000 claims description 13
- 208000003217 Tetany Diseases 0.000 claims description 12
- 208000019695 Migraine disease Diseases 0.000 claims description 11
- 239000000853 adhesive Substances 0.000 claims description 11
- 230000001070 adhesive effect Effects 0.000 claims description 11
- 230000035515 penetration Effects 0.000 claims description 11
- 210000003932 urinary bladder Anatomy 0.000 claims description 10
- 230000033001 locomotion Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 238000002604 ultrasonography Methods 0.000 claims description 9
- 230000001684 chronic effect Effects 0.000 claims description 8
- 206010015037 epilepsy Diseases 0.000 claims description 7
- 208000008589 Obesity Diseases 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 6
- 206010027599 migraine Diseases 0.000 claims description 6
- 235000020824 obesity Nutrition 0.000 claims description 6
- 210000005166 vasculature Anatomy 0.000 claims description 6
- 206010034701 Peroneal nerve palsy Diseases 0.000 claims description 5
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 claims description 2
- 210000002683 foot Anatomy 0.000 description 132
- 238000011282 treatment Methods 0.000 description 85
- 210000003127 knee Anatomy 0.000 description 47
- 208000024891 symptom Diseases 0.000 description 38
- 210000002414 leg Anatomy 0.000 description 33
- 230000008685 targeting Effects 0.000 description 25
- 238000004891 communication Methods 0.000 description 22
- 238000009093 first-line therapy Methods 0.000 description 22
- 208000004296 neuralgia Diseases 0.000 description 21
- 230000004044 response Effects 0.000 description 21
- 239000000463 material Substances 0.000 description 19
- 230000001225 therapeutic effect Effects 0.000 description 19
- 210000003423 ankle Anatomy 0.000 description 18
- 230000009467 reduction Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 238000010304 firing Methods 0.000 description 14
- 230000006698 induction Effects 0.000 description 14
- 230000001939 inductive effect Effects 0.000 description 14
- 238000003491 array Methods 0.000 description 13
- 238000013461 design Methods 0.000 description 13
- 238000002567 electromyography Methods 0.000 description 13
- 208000021722 neuropathic pain Diseases 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 12
- 230000002265 prevention Effects 0.000 description 12
- 208000004983 Phantom Limb Diseases 0.000 description 11
- 206010056238 Phantom pain Diseases 0.000 description 11
- 239000004020 conductor Substances 0.000 description 11
- 230000000399 orthopedic effect Effects 0.000 description 11
- 208000008035 Back Pain Diseases 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 230000003387 muscular Effects 0.000 description 10
- 206010028347 Muscle twitching Diseases 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 206010036596 premature ejaculation Diseases 0.000 description 9
- 206010016654 Fibrosis Diseases 0.000 description 8
- 230000001747 exhibiting effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 206010028836 Neck pain Diseases 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 210000002988 lumbosacral plexus Anatomy 0.000 description 7
- 208000001375 Facial Neuralgia Diseases 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 210000005153 frontal cortex Anatomy 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 238000013160 medical therapy Methods 0.000 description 6
- 230000001537 neural effect Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 201000008482 osteoarthritis Diseases 0.000 description 6
- 206010033799 Paralysis Diseases 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 206010003246 arthritis Diseases 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 230000004118 muscle contraction Effects 0.000 description 5
- 210000003903 pelvic floor Anatomy 0.000 description 5
- 210000001698 popliteal fossa Anatomy 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 208000012790 cranial neuralgia Diseases 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 230000005674 electromagnetic induction Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000012811 non-conductive material Substances 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- -1 wool Polymers 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 241000736305 Marsilea quadrifolia Species 0.000 description 3
- 208000012195 Reunion island Larsen syndrome Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 208000035824 paresthesia Diseases 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 208000020401 Depressive disease Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000001640 Fibromyalgia Diseases 0.000 description 2
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 2
- 208000005615 Interstitial Cystitis Diseases 0.000 description 2
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000023610 Pelvic Floor disease Diseases 0.000 description 2
- 208000031649 Postoperative Nausea and Vomiting Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000000746 body region Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000332 continued effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000003828 downregulation Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 230000030214 innervation Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000000337 motor cortex Anatomy 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 230000002232 neuromuscular Effects 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 238000001020 plasma etching Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 210000003594 spinal ganglia Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 239000003356 suture material Substances 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010001540 Akathisia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 206010069632 Bladder dysfunction Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000012514 Cumulative Trauma disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000032953 Device battery issue Diseases 0.000 description 1
- 206010064687 Device related infection Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 208000005872 Diffuse Esophageal Spasm Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 208000000289 Esophageal Achalasia Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 206010072132 Fracture pain Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 208000007914 Labor Pain Diseases 0.000 description 1
- 208000035945 Labour pain Diseases 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030136 Oesophageal achalasia Diseases 0.000 description 1
- 206010030184 Oesophageal spasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 229910021069 Pd—Co Inorganic materials 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010054048 Postoperative ileus Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010066962 Procedural nausea Diseases 0.000 description 1
- 206010066963 Procedural vomiting Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010072005 Spinal pain Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 240000004543 Vicia ervilia Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000003728 Vulvodynia Diseases 0.000 description 1
- 206010069055 Vulvovaginal pain Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 201000000621 achalasia Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006514 bruxism Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011340 continuous therapy Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010019465 hemiparesis Diseases 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 238000013150 knee replacement Methods 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000000118 neural pathway Anatomy 0.000 description 1
- 230000010004 neural pathway Effects 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 210000000929 nociceptor Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000037325 pain tolerance Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 210000004514 sphincter of oddi Anatomy 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 208000002320 spinal muscular atrophy Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000001738 temporomandibular joint Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14770365.6A EP2968910A4 (en) | 2013-03-15 | 2014-03-13 | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
| JP2016501950A JP2016515869A (ja) | 2013-03-15 | 2014-03-13 | 手のひら及び足底の表面上での経皮的な刺激のための方法及び装置 |
| CA2906558A CA2906558A1 (en) | 2013-03-15 | 2014-03-13 | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/840,936 US9339641B2 (en) | 2006-01-17 | 2013-03-15 | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US13/840,936 | 2013-03-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2014151431A2 true WO2014151431A2 (en) | 2014-09-25 |
| WO2014151431A3 WO2014151431A3 (en) | 2014-11-13 |
Family
ID=51581640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2014/025718 WO2014151431A2 (en) | 2013-03-15 | 2014-03-13 | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2968910A4 (ja) |
| JP (1) | JP2016515869A (ja) |
| CA (1) | CA2906558A1 (ja) |
| WO (1) | WO2014151431A2 (ja) |
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016069687A3 (en) * | 2014-10-31 | 2016-06-23 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| WO2016106182A1 (en) | 2014-12-23 | 2016-06-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Devices, systems and methods for treating urological and gastrointestinal disorders by electrical stimulation of the foot |
| US9452287B2 (en) | 2013-01-21 | 2016-09-27 | Cala Health, Inc. | Devices and methods for controlling tremor |
| EP2968910A4 (en) * | 2013-03-15 | 2016-11-02 | Emkinetics Inc | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
| US9630004B2 (en) | 2006-01-17 | 2017-04-25 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US9802041B2 (en) | 2014-06-02 | 2017-10-31 | Cala Health, Inc. | Systems for peripheral nerve stimulation to treat tremor |
| WO2018125538A1 (en) * | 2016-12-27 | 2018-07-05 | Avent, Inc. | Article for treating diabetic peripheral neuropathy |
| WO2018125013A1 (en) * | 2016-12-31 | 2018-07-05 | Istanbul Teknik Universitesi | Electronic textile based rheumatoid arthritis therapy glove |
| US10765856B2 (en) | 2015-06-10 | 2020-09-08 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US10814130B2 (en) | 2016-07-08 | 2020-10-27 | Cala Health, Inc. | Dry electrodes for transcutaneous nerve stimulation |
| CN112242051A (zh) * | 2019-07-19 | 2021-01-19 | 江苏安惠医疗器械有限公司 | 子端机和康健装置以及康健装置的控制方法 |
| US11141219B1 (en) | 2016-08-16 | 2021-10-12 | BTL Healthcare Technologies, a.s. | Self-operating belt |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| JP2022001277A (ja) * | 2016-01-21 | 2022-01-06 | カラ ヘルス, インコーポレイテッドCala Health, Inc. | 過活動膀胱に関連する疾患を治療するための末梢神経調節のためのシステム、方法およびデバイス |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| WO2022038187A1 (en) * | 2020-08-18 | 2022-02-24 | Sky Medical Technology Ltd | Treatment of ischemia |
| US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11331480B2 (en) | 2017-04-03 | 2022-05-17 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11596785B2 (en) | 2015-09-23 | 2023-03-07 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11963901B2 (en) | 2019-12-28 | 2024-04-23 | Jeffrey Bennett | Apparatus and method of treating an approaching physiological event and increasing an intensity of the event |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6100985B1 (ja) * | 2016-06-23 | 2017-03-22 | 正悦 袴田 | 家庭用電気治療器 |
| KR102654641B1 (ko) * | 2016-10-05 | 2024-04-04 | 스팀비아 에스.알.오. | 신경조절을 위한 장치 및 방법 |
| US11638814B2 (en) | 2016-10-05 | 2023-05-02 | Tesla Medical S.R.O. | Method for neuromodulation treatment of neurodegenerative disease |
| US11839762B2 (en) | 2016-10-05 | 2023-12-12 | Stimvia S.R.O. | Neuromodulation medical treatment device |
| US11896824B2 (en) | 2016-10-05 | 2024-02-13 | Stimvia S.R.O. | Method for neuromodulation treatment of low urinary tract dysfunction |
| JP6873238B2 (ja) * | 2016-11-17 | 2021-05-19 | ブレインラボ アーゲー | 時間同期した脳深部刺激の最適化 |
| US11446490B2 (en) | 2019-04-05 | 2022-09-20 | Tesla Medical S.R.O. | Method for a neuromodulation treatment |
| WO2023157718A1 (ja) * | 2022-02-18 | 2023-08-24 | ニプロ株式会社 | 医療機器 |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5158080A (en) * | 1990-11-08 | 1992-10-27 | Medtronic, Inc. | Muscle tone |
| US5562707A (en) * | 1993-10-13 | 1996-10-08 | Sim & Mcburney | Garment for applying controlled electrical stimulation to restore motor function |
| US20040054393A1 (en) * | 2000-01-21 | 2004-03-18 | Goran Stemme | Medical electrode |
| US6735474B1 (en) * | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
| US20040127939A1 (en) * | 2002-08-27 | 2004-07-01 | Woodside Biomedical, Inc. | Device and method for nausea suppression |
| US20040173220A1 (en) * | 2003-03-06 | 2004-09-09 | Harry Jason D. | Method and apparatus for improving human balance and gait and preventing foot injury |
| US20050277998A1 (en) * | 2004-02-11 | 2005-12-15 | Tracey Michael R | System and method for nerve stimulation |
| US20070021712A1 (en) * | 2002-04-05 | 2007-01-25 | Bernard Robert M | Method and apparatus for delivery of therapeutic agents |
| US20080058874A1 (en) * | 2006-09-01 | 2008-03-06 | Randy Westlund | Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity |
| US20080177347A1 (en) * | 2003-10-15 | 2008-07-24 | Tehrani Amir J | Method for treating a subject having neuromuscular impairment of the diaphragm |
| US20080300655A1 (en) * | 2007-05-31 | 2008-12-04 | Pacesetter, Inc. | Techniques to monitor and trend nerve damage and recovery |
| US20090030337A1 (en) * | 1997-07-01 | 2009-01-29 | Gozani Shai N | Methods for the assessment of neuromuscular function by F-wave latency |
| US20090054950A1 (en) * | 2005-03-02 | 2009-02-26 | Continence Control Systems International Pyt Ltd. | Method and Apparatus for Treating Incontinence |
| US20100318009A1 (en) * | 2005-12-16 | 2010-12-16 | Solomon Tony Stanley | Therapeutic device that provides stimulation to an immobilized extremity |
| US20120059432A1 (en) * | 2010-09-07 | 2012-03-08 | Aalborg Universitet | Method and device for reflex-based functional gait training |
| US20120302821A1 (en) * | 2009-10-26 | 2012-11-29 | Emkinetics, Inc. | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
| US20130006322A1 (en) * | 2009-10-01 | 2013-01-03 | University Of Pittsburgh Of The Commonwealth Syste | Non-invasive method to treat urological and gastrointestinal disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9339641B2 (en) * | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| AU2009266861B2 (en) * | 2008-07-02 | 2014-06-26 | Sage Products, Llc | Systems and methods for automated muscle stimulation |
| JP2013500080A (ja) * | 2009-07-23 | 2013-01-07 | エムキネティクス， インコーポレイテッド | 伝導性コイルのための冷却システムおよび方法 |
| CN103052424B (zh) * | 2010-06-04 | 2015-12-16 | 大学健康网络 | 功能性电刺激装置和系统及其用途 |
| EP2968910A4 (en) * | 2013-03-15 | 2016-11-02 | Emkinetics Inc | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
-
2014
- 2014-03-13 EP EP14770365.6A patent/EP2968910A4/en not_active Withdrawn
- 2014-03-13 JP JP2016501950A patent/JP2016515869A/ja active Pending
- 2014-03-13 CA CA2906558A patent/CA2906558A1/en not_active Abandoned
- 2014-03-13 WO PCT/US2014/025718 patent/WO2014151431A2/en active Application Filing
Patent Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5158080A (en) * | 1990-11-08 | 1992-10-27 | Medtronic, Inc. | Muscle tone |
| US5562707A (en) * | 1993-10-13 | 1996-10-08 | Sim & Mcburney | Garment for applying controlled electrical stimulation to restore motor function |
| US20090030337A1 (en) * | 1997-07-01 | 2009-01-29 | Gozani Shai N | Methods for the assessment of neuromuscular function by F-wave latency |
| US6735474B1 (en) * | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
| US20040054393A1 (en) * | 2000-01-21 | 2004-03-18 | Goran Stemme | Medical electrode |
| US20070021712A1 (en) * | 2002-04-05 | 2007-01-25 | Bernard Robert M | Method and apparatus for delivery of therapeutic agents |
| US20040127939A1 (en) * | 2002-08-27 | 2004-07-01 | Woodside Biomedical, Inc. | Device and method for nausea suppression |
| US20040173220A1 (en) * | 2003-03-06 | 2004-09-09 | Harry Jason D. | Method and apparatus for improving human balance and gait and preventing foot injury |
| US20080177347A1 (en) * | 2003-10-15 | 2008-07-24 | Tehrani Amir J | Method for treating a subject having neuromuscular impairment of the diaphragm |
| US20050277998A1 (en) * | 2004-02-11 | 2005-12-15 | Tracey Michael R | System and method for nerve stimulation |
| US20110264163A1 (en) * | 2004-02-11 | 2011-10-27 | Ethicon, Inc. | System and Method for Nerve Stimulation |
| US20090054950A1 (en) * | 2005-03-02 | 2009-02-26 | Continence Control Systems International Pyt Ltd. | Method and Apparatus for Treating Incontinence |
| US20100318009A1 (en) * | 2005-12-16 | 2010-12-16 | Solomon Tony Stanley | Therapeutic device that provides stimulation to an immobilized extremity |
| US20080058874A1 (en) * | 2006-09-01 | 2008-03-06 | Randy Westlund | Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity |
| US20080300655A1 (en) * | 2007-05-31 | 2008-12-04 | Pacesetter, Inc. | Techniques to monitor and trend nerve damage and recovery |
| US20130006322A1 (en) * | 2009-10-01 | 2013-01-03 | University Of Pittsburgh Of The Commonwealth Syste | Non-invasive method to treat urological and gastrointestinal disorders |
| US20120302821A1 (en) * | 2009-10-26 | 2012-11-29 | Emkinetics, Inc. | Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues |
| US20120059432A1 (en) * | 2010-09-07 | 2012-03-08 | Aalborg Universitet | Method and device for reflex-based functional gait training |
Cited By (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630004B2 (en) | 2006-01-17 | 2017-04-25 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US11844943B2 (en) | 2006-10-02 | 2023-12-19 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US11247053B2 (en) | 2006-10-02 | 2022-02-15 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US11628300B2 (en) | 2006-10-02 | 2023-04-18 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US10850090B2 (en) | 2013-01-21 | 2020-12-01 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US10625074B2 (en) | 2013-01-21 | 2020-04-21 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US9452287B2 (en) | 2013-01-21 | 2016-09-27 | Cala Health, Inc. | Devices and methods for controlling tremor |
| EP2968910A4 (en) * | 2013-03-15 | 2016-11-02 | Emkinetics Inc | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
| US10905879B2 (en) | 2014-06-02 | 2021-02-02 | Cala Health, Inc. | Methods for peripheral nerve stimulation |
| US10179238B2 (en) | 2014-06-02 | 2019-01-15 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| US10549093B2 (en) | 2014-06-02 | 2020-02-04 | Cala Health, Inc. | Method for peripheral nerve stimulation |
| US10173060B2 (en) | 2014-06-02 | 2019-01-08 | Cala Health, Inc. | Methods for peripheral nerve stimulation |
| US9802041B2 (en) | 2014-06-02 | 2017-10-31 | Cala Health, Inc. | Systems for peripheral nerve stimulation to treat tremor |
| US10960207B2 (en) | 2014-06-02 | 2021-03-30 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| US10561839B2 (en) | 2014-06-02 | 2020-02-18 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| AU2019229441B2 (en) * | 2014-10-31 | 2021-02-11 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| JP2017533024A (ja) * | 2014-10-31 | 2017-11-09 | アヴェント インコーポレイテッド | 後脛骨神経刺激を介して医学的状態をモニタリングまたは治療する方法及びシステム |
| WO2016069687A3 (en) * | 2014-10-31 | 2016-06-23 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| CN107106841A (zh) * | 2014-10-31 | 2017-08-29 | 阿文特公司 | 经由胫后神经刺激来监测和治疗病症的方法和系统 |
| EP3434318A1 (en) * | 2014-10-31 | 2019-01-30 | Avent, Inc. | System for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| AU2021202989B2 (en) * | 2014-10-31 | 2023-06-15 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| EP3434320A1 (en) * | 2014-10-31 | 2019-01-30 | Avent, Inc. | System for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| EP3434319A1 (en) * | 2014-10-31 | 2019-01-30 | Avent, Inc. | System for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| CN107106841B (zh) * | 2014-10-31 | 2021-06-25 | 阿文特公司 | 经由胫后神经刺激来监测和治疗病症的方法和系统 |
| US10478612B2 (en) | 2014-10-31 | 2019-11-19 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| AU2019229442B2 (en) * | 2014-10-31 | 2021-02-11 | Avent, Inc. | Method and system for monitoring and treating a medical condition via posterior tibial nerve stimulation |
| US11794009B2 (en) | 2014-12-23 | 2023-10-24 | University of Pittsburgh—of the Commonwealth System of Higher Education | Devices, systems and methods for treating urological and gastrointestinal disorders by electrical stimulation of the foot |
| WO2016106182A1 (en) | 2014-12-23 | 2016-06-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Devices, systems and methods for treating urological and gastrointestinal disorders by electrical stimulation of the foot |
| US10765856B2 (en) | 2015-06-10 | 2020-09-08 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11596785B2 (en) | 2015-09-23 | 2023-03-07 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11918806B2 (en) | 2016-01-21 | 2024-03-05 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation of the leg |
| JP2022001277A (ja) * | 2016-01-21 | 2022-01-06 | カラ ヘルス, インコーポレイテッドCala Health, Inc. | 過活動膀胱に関連する疾患を治療するための末梢神経調節のためのシステム、方法およびデバイス |
| US11344722B2 (en) | 2016-01-21 | 2022-05-31 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11602629B2 (en) | 2016-05-03 | 2023-03-14 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including rf and electrical energy |
| US11883643B2 (en) | 2016-05-03 | 2024-01-30 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including RF and electrical energy |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11691024B2 (en) | 2016-05-10 | 2023-07-04 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11590356B2 (en) | 2016-05-10 | 2023-02-28 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11623083B2 (en) | 2016-05-23 | 2023-04-11 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11458307B2 (en) | 2016-05-23 | 2022-10-04 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| US11896821B2 (en) | 2016-05-23 | 2024-02-13 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11878162B2 (en) | 2016-05-23 | 2024-01-23 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11628308B2 (en) | 2016-07-01 | 2023-04-18 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11524171B2 (en) | 2016-07-01 | 2022-12-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11794029B2 (en) | 2016-07-01 | 2023-10-24 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11497925B2 (en) | 2016-07-01 | 2022-11-15 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11607556B2 (en) | 2016-07-01 | 2023-03-21 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11679270B2 (en) | 2016-07-01 | 2023-06-20 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US10814130B2 (en) | 2016-07-08 | 2020-10-27 | Cala Health, Inc. | Dry electrodes for transcutaneous nerve stimulation |
| US11141219B1 (en) | 2016-08-16 | 2021-10-12 | BTL Healthcare Technologies, a.s. | Self-operating belt |
| US11896299B2 (en) | 2016-08-16 | 2024-02-13 | Btl Healthcare Technologies A.S. | Modular treatment device |
| US11471677B2 (en) | 2016-12-27 | 2022-10-18 | Avent, Inc. | Article and method for treating diabetic peripheral neuropathy |
| AU2017387791B2 (en) * | 2016-12-27 | 2022-04-28 | Avent, Inc. | Article for treating diabetic peripheral neuropathy |
| WO2018125538A1 (en) * | 2016-12-27 | 2018-07-05 | Avent, Inc. | Article for treating diabetic peripheral neuropathy |
| GB2572926B (en) * | 2016-12-31 | 2022-02-02 | Univ Istanbul Teknik | Electronic textile based rheumatoid arthritis therapy glove |
| GB2572926A (en) * | 2016-12-31 | 2019-10-16 | Univ Istanbul Teknik | Electronic textile based rheumatoid arthritis therapy glove |
| WO2018125013A1 (en) * | 2016-12-31 | 2018-07-05 | Istanbul Teknik Universitesi | Electronic textile based rheumatoid arthritis therapy glove |
| US11331480B2 (en) | 2017-04-03 | 2022-05-17 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| US11484725B2 (en) | 2019-04-11 | 2022-11-01 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| CN112242051A (zh) * | 2019-07-19 | 2021-01-19 | 江苏安惠医疗器械有限公司 | 子端机和康健装置以及康健装置的控制方法 |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US11963901B2 (en) | 2019-12-28 | 2024-04-23 | Jeffrey Bennett | Apparatus and method of treating an approaching physiological event and increasing an intensity of the event |
| US11813451B2 (en) | 2020-05-04 | 2023-11-14 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11826565B2 (en) | 2020-05-04 | 2023-11-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11806528B2 (en) | 2020-05-04 | 2023-11-07 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11679255B2 (en) | 2020-05-04 | 2023-06-20 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| WO2022038187A1 (en) * | 2020-08-18 | 2022-02-24 | Sky Medical Technology Ltd | Treatment of ischemia |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016515869A (ja) | 2016-06-02 |
| EP2968910A2 (en) | 2016-01-20 |
| WO2014151431A3 (en) | 2014-11-13 |
| EP2968910A4 (en) | 2016-11-02 |
| CA2906558A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11844943B2 (en) | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | |
| US9630004B2 (en) | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | |
| US9757584B2 (en) | Methods and devices for performing electrical stimulation to treat various conditions | |
| AU2011305581B2 (en) | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | |
| US20220088373A1 (en) | Methods and devices for performing electrical stimulation to treat various conditions | |
| US20180050216A9 (en) | Methods and devices for treating migraines with electromagnetic stimulation | |
| WO2014151431A2 (en) | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces | |
| US9610459B2 (en) | Cooling systems and methods for conductive coils | |
| US20160074671A1 (en) | Method of treating or alleviating a patient with incontinence | |
| WO2011011748A1 (en) | Method and apparatus for magnetic induction therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14770365 Country of ref document: EP Kind code of ref document: A2 |
|
| ENP | Entry into the national phase |
Ref document number: 2016501950 Country of ref document: JP Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2906558 Country of ref document: CA |
|
| REEP | Request for entry into the european phase |
Ref document number: 2014770365 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2014770365 Country of ref document: EP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14770365 Country of ref document: EP Kind code of ref document: A2 |